Schedule 13G ownership disclosure
Viridian Therapeutics Inc
Security class unavailable · CUSIP: 92790C104
Event date: 2021-09-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-21-009866
- Form type
- SC 13G
- Filer
- TCG Crossover Management, LLC
- CIK
- CIK 1839948
- Filed
- Sep 29, 2021
- Reporting period
- Sep 23, 2021
- Description
- Schedule 13G beneficial ownership